Previous studies showed that some proteoglycans, such as glypicans, agrin, and versican, play a key role in the development of liver cancer, and heparan sulfate proteoglycans were regarded to be the critical targets for the diagnosis and therapy of CRC [72, 73]. This evidence concerns the gene GPC1 and colorectal carcinoma.